Patricia Maeda

415 citations
16 papers · 168 indexed · h-index 7

Patricia Maeda

14 papers receiving 168 citations

Peers

Patricia Maeda
Comparison fields: 5 of 38
  • Endocrinology, Diabetes and Metabolism 58
  • Oncology 82
  • Cancer Research 28
  • Pulmonary and Respiratory Medicine 54
  • Pathology and Forensic Medicine 21
Replace Qinghai Ji with:
Qinghai Ji China
Cristina Pizzimenti Italy
Vinay Gudena United States
Barbara Scepura United States
Jan‐Willem B. de Groot Netherlands
Karim Boudadi United States
Eden C. Payabyab United States
Kylie Prutisto-Chang United States
Donna C. Ferguson United States
Thais Maloberti Italy
Patricia Maeda relative to Qinghai Ji China Qinghai Ji's profile →
Citations per field
00.5×
Qinghai Ji · 1×
Citations per year

Countries citing papers authored by Patricia Maeda

Since Specialization
Citations

This map shows the geographic impact of Patricia Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Maeda more than expected).

Fields of papers citing papers by Patricia Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Maeda. The network helps show where Patricia Maeda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patricia Maeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patricia Maeda Line = papers co-authored together Patricia Maeda links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 20243
2 20240
3 20240
4 20242
5 202414
6 20233
7 20231
8 20231
9 202223
10 202114
11 202123
12 202027
13 20202
14 201737
15 20165
16 201413

About Patricia Maeda

Patricia Maeda is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 168 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Advanced Breast Cancer Therapies (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer-related Molecular Pathways (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (58 citations), Oncology (82 citations) and Cancer Research (28 citations). Patricia Maeda has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Marcia S. Brose, Vaia Florou, Ignacio Garrido‐Laguna, Glynn Weldon Gilcrease, Chris Nevala-Plagemann, Jonathan Whisenant, Lori J. Wirth, Henri Roché, William J. Gradishar and Bernardo L. Rapoport. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026